Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Spinal Restoration Advances in Low Back Pain Relief Quest - Orthopedic Design & Technology

Spinal Restoration Advances in Low Back Pain Relief Quest

BioStat System gains Notice of Allowance.

Spinal Restoration Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for claims concerning the delivery device and method of use of the Biostat System for the treatment of discogenic low back pain.

“We believe that the design of the Biostat System overcomes significant hurdles to safe delivery of biologic materials to the intervertebral disc,” said Gary Sabins, president and CEO of Spinal Restoration. “The allowance of these claims strengthens Spinal Restoration’s broad intellectual property portfolio and helps to fortify our leadership position in the field of intradiscal biologic therapies.”

The Biostat System combines the Biostat Biologix Fibrin Sealant, a human-derived, biologic tissue sealant, and the Biostat Delivery Device, an application system designed for safe delivery of biologic materials to the intervertebral disc.

Spinal Restoration became the first company to initiate a Phase III study of a biologic therapy for discogenic low back pain in March 2010. The Phase III study will include 260 patients, and is currently enrolling subjects at 20 centers across the United States.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters